Stay updated on PD-1 and NK Immunotherapy Combo in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the PD-1 and NK Immunotherapy Combo in Solid Tumors Clinical Trial page.

Latest updates to the PD-1 and NK Immunotherapy Combo in Solid Tumors Clinical Trial page
- Check6 days agoChange DetectedNotice added about a lapse in government funding and the NIH Clinical Center's operating status, with guidance to check cc.nih.gov and opm.gov. Revision history updated from v3.4.0 to v3.4.1.SummaryDifference0.5%

- Check14 days agoChange DetectedAdds a glossary display, introduces a 'Last Update Submitted that Met QC Criteria' label, adjusts capitalization for No FEAR Act Data, and updates the revision tag to v3.4.0. These are UI/metadata tweaks and do not affect core study contents or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe only change is the revision label updated from v3.3.3 to v3.3.4; no substantive edits to the Study Details page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check49 days agoChange DetectedAdded a Locations section showing Guangdong as a study site and updated the footer to Revision: v3.3.3; the prior Guangdong Locations and HHS Vulnerability Disclosure were removed.SummaryDifference0.3%

- Check78 days agoChange DetectedPublications section updated to clarify that entries are automatically filled from PubMed and may not be about the study, and the revision tag was updated to v3.3.2; the deletion note reiterates PubMed as the source with revision tag v3.2.0.SummaryDifference0.1%

- Check85 days agoChange DetectedRemoved the government funding lapse notice from the page, including references to NIH Clinical Center operating status and opm.gov updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to PD-1 and NK Immunotherapy Combo in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PD-1 and NK Immunotherapy Combo in Solid Tumors Clinical Trial page.